Medicine
Mavenclad 10 mg tablet
Mavenclad 10 mg tablet is a prescription medicine containing Cladribine for oral use, marketed by EMD Serono, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature, 20°C to 25°C (68°F to 77°F), excursions…
Key facts
- Active ingredient (INN)
- Cladribine
- Brand
- Mavenclad
- Strength
- 10 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 5 blister pack, 4 blister pack, 6 blister pack and 4 more
- Marketing authorisation holder
- EMD Serono
- Manufacturer
- EMD Serono
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature, 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Store in original package in order to protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01BB04 Cladribine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 April 2019
- Identifiers
- RxCUI 2122634, 2122635, 2122641 +7DailyMed set ID 9c75e30a-a410-40f1-b653-04d532bd9144NDC 44087-4000Application NDA022561
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 blister pack in 1 carton / 2 tablet in 1 blister pack | 44087-4000-0 | EMD Serono | 1 April 2019 |
| 4 blister pack in 1 carton / 1 tablet in 1 blister pack | 44087-4000-4 | EMD Serono | 1 April 2019 |
| 5 blister pack in 1 carton / 1 tablet in 1 blister pack | 44087-4000-5 | EMD Serono | 1 April 2019 |
| 6 blister pack in 1 carton / 1 tablet in 1 blister pack | 44087-4000-6 | EMD Serono | 1 April 2019 |
| 7 blister pack in 1 carton / 1 tablet in 1 blister pack | 44087-4000-7 | EMD Serono | 1 April 2019 |
| 8 blister pack in 1 carton / 1 tablet in 1 blister pack | 44087-4000-8 | EMD Serono | 1 April 2019 |
| 9 blister pack in 1 carton / 1 tablet in 1 blister pack | 44087-4000-9 | EMD Serono | 1 April 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Cladribine 10 mg tablet.
Other strengths and forms of Cladribine
Clinical summary
Cladribine is a purine antimetabolite indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults, among other approved uses. MedsAcross supplies Cladribine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CladribineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Mavenclad prescribing information (EMD Serono) · U.S. National Library of Medicine, DailyMed
- Litak: European public assessment report (EPAR) · European Medicines Agency
- Mavenclad: European public assessment report (EPAR) · European Medicines Agency
Need Mavenclad 10 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.